02:58 PM EDT, 06/24/2024 (MT Newswires) -- (Updates with additional details in the third and fourth paragraphs.)

Novo Nordisk ( NVO ) said Monday it plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, North Carolina.

The expansion will add 1.4 million square feet of production space for aseptic manufacturing and finished production processes to help cover the demand for weight-loss drugs and other prescriptions. The new project will add 1,000 new jobs, Novo Nordisk ( NVO ) added.

The company said it had already begun early clearing and foundational work to prepare the 56-acre facility footprint and expects to finalize construction between 2027 and 2029.

Novo Nordisk ( NVO ) plans to spend $6.8 billion this year to expand production, up from the $3.9 billion it spent in 2023 to increase supply, the company said.

Price: 141.84, Change: -0.12, Percent Change: -0.08